Millipore Sigma Vibrant Logo
Attention: We have moved. Merck Millipore products are no longer available for purchase on MerckMillipore.com.Learn More

MABS2056-25UL Anti-Nardilysin (NRDC) Antibody, clone 102

MABS2056-25UL
25 µL  
Purchase on Sigma-Aldrich

Aperçu

Replacement Information
Description
Catalogue NumberMABS2056-25UL
DescriptionAnti-Nardilysin (NRDC) Antibody, clone 102
Alternate Names
  • N-arginine dibasic convertase
  • NRD convertase
  • NRDC
  • NRD-C
  • Nardilysin convertase
Background InformationNardilysin (UniProt: O43847; also known as EC: 3.4.24.61, N-arginine dibasic convertase, NRD convertase, NRD-C, Nardilysin convertase) is encoded by the NRDC (also known as NRD1) gene (Gene ID: 4898) in human. NRD-C is a metalloendopeptidase of the M16 family that cleaves peptides on the N-terminus of arginine residues in dibasic pairs. It is synthesized with a signal peptide (aa 1-20), which is subsequently cleaved off in the mature form. It promotes ecto-domain shedding of the precursor forms of various growth factors and cytokines by enhancing the protease activities of ADAM proteins. NRD-C is reported to bind to the extracellular domain of ADAM17 and directly enhance its catalytic activity. Its levels are shown to be elevated in serum and epithelium of gastric cancer and NRDC knockdown attenuates gastric cancer cell growth in vitro and in xenograft models. In mitochondria, it serves as a co-chaperone for proper folding of alpha-ketoglutarate dehydrogenase (alpha-KGDH) and absence of NRDC can lead to a severe reduction of alpha-KGDH. NRD-C is shown to inhibit pancreatitis and suppresses pancreatic ductal adenocarcinoma in mice. Its deletion in pancreatic tissue is reported to leads to spontaneous chronic pancreatitis concomitant with acinar-to-ductal conversion, increased apoptosis, and pancreatic atrophy in mice. (Ref.: Kanda, K., et al. (2012). EMBO Mol. Med. 4(5); 396-411; Yoon WH., et al. (2017). Neuron 93(1); 115-131; Ikuda, K., et al (2018). Gut (In Press; 10.1136/gutjnl-2017-315425).
References
Product Information
FormatPurified
PresentationPurified mouse monoclonal antibody IgG1 in buffer containing 0.1 M Tris-Glycine (pH 7.4), 150 mM NaCl with 0.05% sodium azide.
Applications
ApplicationAnti-Nardilysin (NRDC), clone 102, Cat. No. MABS2056, is a mouse monoclonal antibody that detects Nardilysin (NRDC) and has been tested for use in Immunoprecipitation, Western Blotting, Immunocytochemistry, and Immunohistochemistry.
Key Applications
  • Immunoprecipitation
  • Western Blotting
  • Immunocytochemistry
  • Immunohistochemistry
Application NotesImmunoprecipitation Analysis: A representative lot immunoprecipitated Nardilysin (NRDC) in Immunoprecipitation applications (Ohno, M., et. al. (2014). Neurobiol Aging. 35(1):213-22).

Western Blotting Analysis: A representative lot detected Nardilysin (NRDC) in Western Blotting applications (Kanda, K., et. al. (2012). EMBO Mol Med. 4(5):396-411).

Immunocytochemistry (ICC): A representative lot detected Nardilysin (NRDC) in Immunocytochemistry applications. (Ito, Y., et al. (2018). Cell. 174(3); 636 - 648; Kanda, K., et al. (2018). JCI Insight. 3(8); e91316).

Immunohistochemistry (IHC): A representative lot detected Nardilysin (NRDC) in Immunohistochemistry applications. (Yoh, T., et al., (2019). Clin. Cancer Res. 25(2); 619-628; Ikuta, K., et al. (2019). Gut. 68(5); 882-892 Kasai, Y., et al. (2017). Cancer Sci. 108(5); 910-917; Chen, PM., et al. (2017). Int. J. Cardiol. 243; 1-8; Kanda, K., et al. (2012). EMBO Mol. Med. 4(5); 396-411).
Biological Information
ImmunogenGST-tagged recombinant fragment corresponding to 80 amino acids from the N-terminal of human Nardilysin.
Clone102
ConcentrationPlease refer to lot specific datasheet.
HostMouse
SpecificityClone 102 is a mouse monoclonal antibody that specifically detects human Nardilysin. It targets an epitope within 80 amino acids from the N-terminal region.
IsotypeIgG1κ
Species Reactivity
  • Human
Species Reactivity NoteHuman.
Antibody TypeMonoclonal Antibody
Entrez Gene Number
Gene Symbol
  • NRDC
  • NRD1
Purification MethodProtein G purified
UniProt Number
Molecular Weight~140 kDa observed; 131.70 kDa calculated. Uncharacterized bands may be observed in some lysate(s).
Physicochemical Information
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Quality AssuranceEvaluated by Western Blotting in human testis tissue lysates.

Western Blotting Analysis: A 1:1,000 dilution of this antibody detected Nardilysin (NRDC) in human testis tissue lysates.
Usage Statement
  • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Storage and Shipping Information
Storage ConditionsStable for 1 year at 2-8°C from date of receipt.
Packaging Information
Material Size25 µL
Transport Information
Supplemental Information
Specifications
Global Trade Item Number
Référence GTIN
MABS2056-25UL 04054839997204

Documentation

Anti-Nardilysin (NRDC) Antibody, clone 102 FDS

Titre

Fiche de données de sécurité des matériaux (FDS) 

Anti-Nardilysin (NRDC) Antibody, clone 102 Certificats d'analyse

TitreNuméro de lot
Anti-Nardilysin (NRDC), clone 102 - 3237235 3237235

Références bibliographiques

Aperçu de la référence bibliographiqueNº PubMed
Nardilysin prevents amyloid plaque formation by enhancing α-secretase activity in an Alzheimer's disease mouse model.
Ohno, M; Hiraoka, Y; Lichtenthaler, SF; Nishi, K; Saijo, S; Matsuoka, T; Tomimoto, H; Araki, W; Takahashi, R; Kita, T; Kimura, T; Nishi, E
Neurobiol Aging  35  213-22  2014

Afficher le résumé
23954170 23954170
Nardilysin and ADAM proteases promote gastric cancer cell growth by activating intrinsic cytokine signalling via enhanced ectodomain shedding of TNF-α.
Kanda, K; Komekado, H; Sawabu, T; Ishizu, S; Nakanishi, Y; Nakatsuji, M; Akitake-Kawano, R; Ohno, M; Hiraoka, Y; Kawada, M; Kawada, K; Sakai, Y; Matsumoto, K; Kunichika, M; Kimura, T; Seno, H; Nishi, E; Chiba, T
EMBO Mol Med  4  396-411  2011

Afficher le résumé
22351606 22351606